Commentary Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.46439/allergy.5.042
Mitochondrial disease patients and rotavirus infection complications
Savannah Battleson1, Anna Betler1, Hayden Divers1, Jack Kloecker1, Iradukunda Esperance1, Nicholas Farrell1, Molly Sawyer1, Azhar Rahama1, Ojus Dalvi1, Gary Vanderlaan1,*
- 1Biology Department, Gannon University, Erie, PA, USA
Corresponding Author
Gary Vanderlaan, vanderla002@gannon.edu
Received Date: March 29, 2024
Accepted Date: April 22, 2024
Battleson S, Betler A, Divers H, Kloecker J, Esperance I, Farrell N, et al. Mitochondrial disease patients and rotavirus infection complications. Allergy Infect Dis. 2024;5(1):17-28.
Copyright: © 2024 Battleson S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Haploinsufficiency, Mitochondrial diseases, MAVS, mRNA vaccine, POLG-related disorders, RotaTeq, Rotavirus, VP3
Recommended Articles
Mitochondrial disease patients and rotavirus infection complications
Rotavirus (RV) is an agent of gastroenteritis and, to a lesser extent, neurological manifestations including seizures and epilepsy. Before the development of effective vaccines, rotavirus was among the leading global drivers of life-threatening diarrhea in neonates and children less than five years of age.